Skip to content
PICO Portalanswers from OpenAlex

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease

PaperCitations, authors & open-access status

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease have?

PICO Portalcitation count

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has 9 citations in the OpenAlex counts PICO Portal stores.

When was Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease published?

PICO Portalyear

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has 2023 year in the PICO Portal index.

What is the open-access status of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?

PICO Portaloa status

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease has gold oa status in the PICO Portal index.

What is the DOI of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?

PICO Portaldoi

The DOI for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.

What is the PMID of Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?

PICO Portalpmid

The PMID for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.

What is the OpenAlex record for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease?

PICO Portalopenalex

The OpenAlex for Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial